Trupanion (NASDAQ:TRUP) PT Lowered to $34.00

Trupanion (NASDAQ:TRUP) had its price target cut by investment analysts at Canaccord Genuity Group from $40.00 to $34.00 in a report issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the financial services provider’s stock. Canaccord Genuity Group’s target price would suggest a potential upside of 71.28% from the stock’s previous close.

Several other equities analysts also recently issued reports on TRUP. Stifel Nicolaus boosted their price objective on Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a research report on Friday, February 16th. Evercore ISI reduced their price objective on Trupanion from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, February 20th. Finally, Piper Sandler reduced their price objective on Trupanion from $28.00 to $22.00 and set a “neutral” rating for the company in a research report on Friday. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $32.33.

Trupanion Stock Performance

TRUP stock traded down $3.93 during midday trading on Friday, reaching $19.85. The company had a trading volume of 2,327,393 shares, compared to its average volume of 683,106. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.42. The stock has a 50 day moving average price of $25.67 and a 200 day moving average price of $26.77. Trupanion has a fifty-two week low of $18.45 and a fifty-two week high of $36.82. The firm has a market capitalization of $833.60 million, a PE ratio of -18.38 and a beta of 1.76.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings data on Thursday, May 2nd. The financial services provider reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.18) by $0.02. The business had revenue of $306.12 million during the quarter, compared to the consensus estimate of $300.51 million. Trupanion had a negative return on equity of 15.19% and a negative net margin of 4.03%. The business’s revenue was up 19.4% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.60) earnings per share. Analysts anticipate that Trupanion will post -0.43 earnings per share for the current year.

Hedge Funds Weigh In On Trupanion

Large investors have recently made changes to their positions in the business. Sivia Capital Partners LLC acquired a new stake in Trupanion during the fourth quarter valued at approximately $31,398,000. 8 Knots Management LLC acquired a new stake in shares of Trupanion during the 4th quarter valued at $21,165,000. Wellington Management Group LLP boosted its stake in shares of Trupanion by 34.6% during the 4th quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock worth $74,862,000 after acquiring an additional 630,155 shares in the last quarter. Tudor Investment Corp Et Al bought a new stake in shares of Trupanion during the 3rd quarter worth $4,712,000. Finally, GSA Capital Partners LLP grew its holdings in shares of Trupanion by 376.5% in the 1st quarter. GSA Capital Partners LLP now owns 80,046 shares of the financial services provider’s stock worth $2,210,000 after acquiring an additional 63,247 shares during the last quarter.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.